Bioporto A/S
CSE:BIOPOR

Watchlist Manager

Bioporto A/S

CSE:BIOPOR

Watchlist

Dividends

Price: 1.616 DKK -1.1% Market Closed

Market Cap: 694.3m DKK

Have any thoughts about
Bioporto A/S?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

Add Price Alert

Price Target:

Last Price: 1.616 DKK

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

BIOPOR Alert

Bioporto A/S

1.616

-0.018 (-1.1%)

52 Week Range	1.222 2.965
Price Target

We'll email you a reminder when the closing price reaches DKK.

Save Alert

Choose the stock you wish to monitor with a price alert.

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Bioporto A/S

What unique competitive advantages
does Bioporto A/S hold over its rivals?

What risks and challenges
does Bioporto A/S face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Bioporto A/S.

What unique competitive advantages
does Bioporto A/S hold over its rivals?

What risks and challenges
does Bioporto A/S face in the near future?

Summarize the latest earnings call
of Bioporto A/S.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Bioporto A/S.

Provide P/S
for Bioporto A/S.

Provide P/E
for Bioporto A/S.

Provide P/OCF
for Bioporto A/S.

Provide P/FCFE
for Bioporto A/S.

Provide P/B
for Bioporto A/S.

Provide EV/S
for Bioporto A/S.

Provide EV/GP
for Bioporto A/S.

Provide EV/EBITDA
for Bioporto A/S.

Provide EV/EBIT
for Bioporto A/S.

Provide EV/OCF
for Bioporto A/S.

Provide EV/FCFF
for Bioporto A/S.

Provide EV/IC
for Bioporto A/S.

Show me price targets
for Bioporto A/S made by professional analysts.

What are the Revenue projections
for Bioporto A/S?

How accurate were the past Revenue estimates
for Bioporto A/S?

What are the Net Income projections
for Bioporto A/S?

How accurate were the past Net Income estimates
for Bioporto A/S?

What are the EPS projections
for Bioporto A/S?

How accurate were the past EPS estimates
for Bioporto A/S?

What are the EBIT projections
for Bioporto A/S?

How accurate were the past EBIT estimates
for Bioporto A/S?

Compare the revenue forecasts
for Bioporto A/S with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Bioporto A/S and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Bioporto A/S against its competitors.

Analyze the profit margins
(gross, operating, and net) of Bioporto A/S compared to its peers.

Compare the P/E ratios
of Bioporto A/S against its peers.

Discuss the investment returns and shareholder value creation
comparing Bioporto A/S with its peers.

Analyze the financial leverage
of Bioporto A/S compared to its main competitors.

Show all profitability ratios
for Bioporto A/S.

Provide ROE
for Bioporto A/S.

Provide ROA
for Bioporto A/S.

Provide ROIC
for Bioporto A/S.

Provide ROCE
for Bioporto A/S.

Provide Gross Margin
for Bioporto A/S.

Provide Operating Margin
for Bioporto A/S.

Provide Net Margin
for Bioporto A/S.

Provide FCF Margin
for Bioporto A/S.

Show all solvency ratios
for Bioporto A/S.

Provide D/E Ratio
for Bioporto A/S.

Provide D/A Ratio
for Bioporto A/S.

Provide Interest Coverage Ratio
for Bioporto A/S.

Provide Altman Z-Score Ratio
for Bioporto A/S.

Provide Quick Ratio
for Bioporto A/S.

Provide Current Ratio
for Bioporto A/S.

Provide Cash Ratio
for Bioporto A/S.

What is the historical Revenue growth
over the last 5 years for Bioporto A/S?

What is the historical Net Income growth
over the last 5 years for Bioporto A/S?

What is the current Free Cash Flow
of Bioporto A/S?

Discuss the annual earnings per share (EPS)
trend over the past five years for Bioporto A/S.

EV/IC
Enterprise Value to IC

27.2

Current

22.9

Median

4.6

Industry

Higher than median

Higher than industry value

Enterprise Value to Invested Capital (EV/IC) ratio is a valuation multiple that measures the dollars in Enterprise Value for each dollar of capital invested by shareholders and lenders.

EV/IC

27.2

Enterprise Value

600.8m DKK

Invested Capital

22.1m DKK

All Countries

Forward Multiples

			Market Cap	EV/IC
DK		Bioporto A/S CSE:BIOPOR	701.2m DKK	27.2
FR		Pharnext SCA OTC:PNEXF	6T USD	-1 413 880.6
US		Abbvie Inc NYSE:ABBV	320.1B USD	3.5
US		Amgen Inc NASDAQ:AMGN	147.4B USD	3.1
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	119.4B USD	10.7
US		Gilead Sciences Inc NASDAQ:GILD	113.8B USD	2.2
US	E	Epizyme Inc F:EPE	94.1B EUR	861.8
AU		CSL Ltd ASX:CSL	135.4B AUD	2.9
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	82.6B USD	2.8
US	S	Seagen Inc F:SGT	39.3B EUR	18.4
NL		argenx SE XBRU:ARGX	34.3B EUR	23.3


DK		Bioporto A/S CSE:BIOPOR	Average EV/IC: 95.6 27.2
FR		Pharnext SCA OTC:PNEXF	Negative Multiple: -1 413 880.6
US		Abbvie Inc NYSE:ABBV	3.5
US		Amgen Inc NASDAQ:AMGN	3.1
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	10.7
US		Gilead Sciences Inc NASDAQ:GILD	2.2
US	E	Epizyme Inc F:EPE	861.8
AU		CSL Ltd ASX:CSL	2.9
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	2.8
US	S	Seagen Inc F:SGT	18.4
NL		argenx SE XBRU:ARGX	23.3

EV/IC Forward Multiples

Forward EV/IC multiple is a version of the EV/IC ratio that uses forecasted invested capital for the EV/IC calculation. 1-Year, 2-Years, and 3-Years forwards use invested capital forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

EV/IC

N/A

2-Years Forward

EV/IC

N/A

3-Years Forward

EV/IC

N/A

Bioporto A/S
CSE:BIOPOR

EV/IC
Enterprise Value to IC

EV/IC Forward Multiples

See Also

Company

Help

Tools

Stocks

Bioporto A/S CSE:BIOPOR

EV/IC Enterprise Value to IC

EV/IC Forward Multiples

See Also

Company

Help

Tools

Stocks

Bioporto A/S
CSE:BIOPOR

EV/IC
Enterprise Value to IC